Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00758061
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
6OB | (8E,10S,12Z)-10-hydroxy-6-oxooctadeca- 8,12-dienoic acid | A,B | 2VV4 | 0.74 |  |
HO2 | (9E,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A | 3DBM | 0.71 | |
8PG | (8S,12S)-15S-HYDROXY-9-OXOPROSTA- 10Z,13E-DIEN-1-OIC ACID | A,B | 2G5W | 0.76 | |
FUA | FUSIDIC ACID | A | 1QCA | 0.7 | |
| FUA | FUSIDIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1Q23 | 0.7 | |
| FUA | FUSIDIC ACID | A,B | 2VUF | 0.7 | |
MVB | (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO- 7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO- 4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]- 1-NAPHTHALENOL | A,B,C | 1YA8 | 0.75 | |
803 | LOVASTATIN | A,B | 1CQP | 0.74 | |
DHK | 3-DEHYDROSHIKIMATE | A | 1WE2 | 0.74 | |
| DHK | 3-DEHYDROSHIKIMATE | A,B | 1SFJ | 0.74 | |
| DHK | 3-DEHYDROSHIKIMATE | A,B,C,D,E,F, G,H,I,J,K,L | 1GTZ | 0.74 | |
| DHK | 3-DEHYDROSHIKIMATE | A | 2O7Q | 0.74 | |
| DHK | 3-DEHYDROSHIKIMATE | A | 2O7S | 0.74 | |
AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A,B,E | 1R8Q | 0.7 | |
| AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A | 1RE0 | 0.7 | |
| AFB | 1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO- 1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN- 4-ONE | A,E | 1S9D | 0.7 | |
9OH | (TRANS-12,13-EPOXY)-9-HYDROXY-10(E)- OCTADECENOIC ACID | A | 1IK3 | 0.7 | |
TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | A,B | 1ECM | 0.72 | |
| TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 2CHT | 0.72 | |
| TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | X | 2GTV | 0.72 | |
| TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | H | 1FIG | 0.72 | |
| TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | A,B | 4CSM | 0.72 | |
| TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | A,B | 3CSM | 0.72 | |
| TSA | 8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | B | 2FP2 | 0.72 | |
T24 | (9Z,11E,13S,15Z)-13-hydroxyoctadeca- 9,11,15-trienoic acid | A,B | 3DSI | 0.74 | |
LVA | (3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6- DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}- 1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN- 1-YL)-3,5-DIHYDROXYHEPTANOIC ACID | A,B | 1T02 | 0.78 | |
114 | COMPACTIN | A,B,C,D | 1HW8 | 0.78 | |
RGC | REIDISPONGIOLIDE C | A | 2ASP | 0.72 | |
164 | 2-(3-CARBOXYPROPIONYL)-6-HYDROXY- CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID | A | 1R6W | 0.74 | |
6OC | (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca- 9,12-dienoic acid | A,B | 2VV4 | 0.71 | |
13T | 13-DEOXYTEDANOLIDE | 0,1,3,9,A,B, C,H,J,K,L,M, N,O,Q,R,S,T, U,Y,Z | 2OTJ | 0.72 | |
PG2 | PROSTAGLANDIN D2 | A,B | 1RY0 | 0.73 | |
243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 3DSJ | 0.71 | |
| 243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 2RCH | 0.71 | |
| 243 | (9Z,11E,13S)-13-hydroxyoctadeca- 9,11-dienoic acid | A,B | 2VST | 0.71 | |
E4H | (3R,4S,5S,7R,9E,11R,12R)-12-ETHYL- 4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC- 9-ENE-2,8-DIONE | A,B | 2HFK | 0.75 | |
9HO | (9S,10E,12Z)-9-hydroxyoctadeca- 10,12-dienoic acid | A,B | 2VSR | 0.71 | |
SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A,B | 2IYR | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 3BAF | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 3DOO | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 1U8A | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 1ZUI | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A,B | 2EV9 | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A,B,C,D | 2HK9 | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A,B | 2D5C | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2IYQ | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2AA9 | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 1ZYU | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2GPT | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2G1K | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2AAY | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2IYX | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2DFN | 0.74 | |
| SKM | (3R,4S,5R)-3,4,5-TRIHYDROXYCYCLOHEX- 1-ENE-1-CARBOXYLIC ACID | A | 2IYS | 0.74 | |
FA1 | 2,3 -ANHYDRO-QUINIC ACID | A | 1H0R | 0.71 | |
| FA1 | 2,3 -ANHYDRO-QUINIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1GU1 | 0.71 | |
| FA1 | 2,3 -ANHYDRO-QUINIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 2C57 | 0.71 | |
MRC | MUPIROCIN | A | 1JZS | 0.75 | |
| MRC | MUPIROCIN | A,T | 1FFY | 0.75 | |
| MRC | MUPIROCIN | A | 1QU3 | 0.75 | |
| MRC | MUPIROCIN | A,T | 1QU2 | 0.75 | |
RCL | RICINOLEIC ACID | A | 2CM4 | 0.71 | |
| RCL | RICINOLEIC ACID | A | 2CM9 | 0.71 | |
| RCL | RICINOLEIC ACID | A | 1FK7 | 0.71 | |
PGX | 7-[6-(3-HYDROPEROXY-OCT-1-ENYL)- 2,3-DIOXA-BICYCLO[2.2.1]HEPT-5- YL]-HEPT-5-ENOIC ACID | A,B,C,D | 1DDX | 0.7 | |
EAH | (5S,7E,9E,11Z,14Z)-5-hydroxyicosa- 7,9,11,14-tetraenoic acid | A | 3DZT | 0.73 | |
SIM | SIMVASTATIN | A,B,C,D | 1HW9 | 0.76 | |
TSO | (1R,3S,5S,8R)-8-HYDROXY-2-OXABICYCLO[3.3.1]NON- 6-ENE-3,5-DICARBOXYLIC ACID | A,B,C,D | 2W1A | 0.72 | |
5HE | (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa- 6,8,11,14,17-pentaenoic acid | A,B | 2VV2 | 0.72 | |